Table 3.
Multivariate analysis to assess the association of clinicopathological parameters with prognosis of HPC
| Parameter | OS | DFS | ||
|---|---|---|---|---|
| Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | |
| PD-1+ CD8+ T cell | 5.575 (0.704 ~ 44.145) | 0.104 | 3.068 (0.606 ~ 15.538) | 0.176 |
| Differentiation | – | – | 1.559 (0.368 ~ 6.604) | 0.546 |
| Clinical stage | 1.737 (0.366 ~ 8.248) | 0.487 | 1.528 (0.585 ~ 3.993) | 0.387 |
| Lymph node metastasis | 2.880 (0.938 ~ 8.844) | 0.065 | 2.130 (0.836 ~ 5.428) | 0.113 |
DFS: disease-free survival; OS: overall survival
P values in bold denote significance at < 0.05 level